Human papillomavirus-related disease in men: not just a women's issue.

PubWeight™: 1.53‹?› | Rank: Top 4%

🔗 View Article (PMC 2871537)

Published in J Adolesc Health on April 01, 2010

Authors

Joel M Palefsky1

Author Affiliations

1: Department of Medicine, University of California, San Francisco, California 94143, USA. joel.Palefsky@ucsf.edu

Articles citing this

Targeted human papillomavirus vaccination of men who have sex with men in the USA: a cost-effectiveness modelling analysis. Lancet Infect Dis (2010) 2.13

Including males in Canadian human papillomavirus vaccination programs: a policy analysis. CMAJ (2016) 1.55

Sexual orientation disparities in cancer-related risk behaviors of tobacco, alcohol, sexual behaviors, and diet and physical activity: pooled Youth Risk Behavior Surveys. Am J Public Health (2013) 1.26

Burden of human papillomavirus infection and related comorbidities in men: implications for research, disease prevention and health promotion among Hispanic men. P R Health Sci J (2010) 1.22

HIV and other sexually transmitted infections among men who have sex with men recruited by RDS in Buenos Aires, Argentina: high HIV and HPV infection. PLoS One (2012) 1.22

The burden of human papillomavirus infections and related diseases in sub-saharan Africa. Vaccine (2013) 1.18

Sex-specific immunization for sexually transmitted infections such as human papillomavirus: insights from mathematical models. PLoS Med (2011) 1.10

Estimation of geographic variation in human papillomavirus vaccine uptake in men and women: an online survey using facebook recruitment. J Med Internet Res (2014) 1.07

Towards the eradication of HPV infection through universal specific vaccination. BMC Public Health (2013) 1.01

Designing messages to motivate parents to get their preteenage sons vaccinated against human papillomavirus. Perspect Sex Reprod Health (2012) 0.99

Human papillomavirus (HPV): college male's knowledge, perceived risk, sources of information, vaccine barriers and communication. J Mens Health (2011) 0.92

Correlation between HPV sperm infection and male infertility. Asian J Androl (2013) 0.92

Mediation by peer violence victimization of sexual orientation disparities in cancer-related tobacco, alcohol, and sexual risk behaviors: pooled youth risk behavior surveys. Am J Public Health (2014) 0.91

Genital Human Papillomavirus Infection Progression to External Genital Lesions: The HIM Study. Eur Urol (2015) 0.88

Incremental benefits of male HPV vaccination: accounting for inequality in population uptake. PLoS One (2014) 0.86

Awareness and knowledge of human papillomavirus (HPV) infection among high-risk men of Hispanic origin attending a sexually transmitted infection (STI) clinic. BMC Infect Dis (2012) 0.86

Lessons from Australia: human papillomavirus is not a major risk factor for esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev (2010) 0.82

Predicting human papillomavirus vaccine intentions of college-aged males: an examination of parents' and son's perceptions. J Am Coll Health (2012) 0.82

Cost-effectiveness of vaccination with a quadrivalent HPV vaccine in Germany using a dynamic transmission model. Health Econ Rev (2012) 0.81

Human papilloma virus vaccines: Current scenario. Indian J Sex Transm Dis (2011) 0.80

Laboratory and clinical aspects of human papillomavirus testing. Crit Rev Clin Lab Sci (2012) 0.80

Role and uptake of human papillomavirus vaccine in adolescent health in the United States. Adolesc Health Med Ther (2011) 0.80

HPV vaccine: Current status and future directions. Med J Armed Forces India (2015) 0.79

Exploring the implications of HPV infection for head and neck cancer. Sex Transm Infect (2015) 0.79

Immunological treatment options for locoregionally advanced head and neck squamous cell carcinoma. Int Rev Immunol (2012) 0.78

Distribution of genital human papillomavirus genotypes in benign clinical manifestations among men from Northern Spain. BMC Public Health (2016) 0.78

Rome Consensus Conference - statement; human papilloma virus diseases in males. BMC Public Health (2013) 0.77

Parents' and sons' beliefs in sexual disinhibition after human papillomavirus vaccination. Sex Transm Dis (2013) 0.76

Trends in genital warts by socioeconomic status after the introduction of the national HPV vaccination program in Australia: analysis of national hospital data. BMC Infect Dis (2016) 0.76

Disparities by Sexual Orientation in Frequent Engagement in Cancer-Related Risk Behaviors: A 12-Year Follow-Up. Am J Public Health (2016) 0.76

The Prevalence and Genotype Distribution of Human Papillomavirus in the Genital Tract of Males in Iran. Jundishapur J Microbiol (2015) 0.75

Quadrivalent human papillomavirus (HPV) types 6, 11, 16, 18 vaccine for the prevention of genital warts in males: profile report. demail@springer.com. Drugs R D (2012) 0.75

Analysis of longitudinal multivariate outcome data from couples cohort studies: application to HPV transmission dynamics. J Am Stat Assoc (2015) 0.75

HIV-Infected Young Men Demonstrate Appropriate Risk Perceptions and Beliefs about Safer Sexual Behaviors after Human Papillomavirus Vaccination. AIDS Behav (2017) 0.75

Articles cited by this

Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med (2003) 31.67

Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med (2007) 16.39

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med (2007) 15.40

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med (2007) 12.17

Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med (2002) 10.80

Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev (2005) 9.47

Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst (2008) 8.70

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet (2007) 8.55

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet (2006) 7.83

Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med (2008) 7.71

Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med (2006) 5.69

Prevalence of HPV infection among men: A systematic review of the literature. J Infect Dis (2006) 4.67

Chapter 1: Human papillomavirus and cervical cancer--burden and assessment of causality. J Natl Cancer Inst Monogr (2003) 4.35

Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States. BMJ (2009) 4.18

Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer (2004) 4.04

The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States. Cancer Epidemiol Biomarkers Prev (2008) 3.93

Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst (2000) 3.77

Genital human papillomavirus infection in men: incidence and risk factors in a cohort of university students. J Infect Dis (2007) 3.48

Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000. Cancer (2004) 3.40

Evaluation of genital sites and sampling techniques for detection of human papillomavirus DNA in men. J Infect Dis (2004) 3.18

Model for assessing human papillomavirus vaccination strategies. Emerg Infect Dis (2007) 2.93

Determinants of prevalence, acquisition, and persistence of human papillomavirus in healthy Mexican military men. Cancer Epidemiol Biomarkers Prev (2005) 2.86

Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis (1998) 2.82

Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer (2005) 2.79

Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy. AIDS (2008) 2.74

The health and economic burden of genital warts in a set of private health plans in the United States. Clin Infect Dis (2003) 2.72

Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea. J Infect Dis (2004) 2.63

Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol (2004) 2.59

Age-specific prevalence, incidence, and duration of human papillomavirus infections in a cohort of 290 US men. J Infect Dis (2008) 2.56

Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS (2005) 2.56

Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr (2008) 2.44

Six-month natural history of oral versus cervical human papillomavirus infection. Int J Cancer (2007) 2.37

Etiology of squamous cell carcinoma of the penis. Scand J Urol Nephrol Suppl (2000) 2.23

Comparison of patient- and clinician-collected anal cytology samples to screen for human papillomavirus-associated anal intraepithelial neoplasia in men who have sex with men. Ann Intern Med (2008) 2.22

Age-Specific prevalence of anal human papillomavirus infection in HIV-negative sexually active men who have sex with men: the EXPLORE study. J Infect Dis (2004) 2.21

Concordance of specific human papillomavirus types in sex partners is more prevalent than would be expected by chance and is associated with increased viral loads. Clin Infect Dis (2005) 2.20

Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. J Infect Dis (2000) 2.16

Penile cancer: epidemiology, pathogenesis and prevention. World J Urol (2008) 2.14

Anal human papillomavirus infection is associated with HIV acquisition in men who have sex with men. AIDS (2009) 2.12

Anal human papillomavirus infection in women and its relationship with cervical infection. Cancer Epidemiol Biomarkers Prev (2005) 2.11

Duration and clearance of anal human papillomavirus (HPV) infection among women: the Hawaii HPV cohort study. Clin Infect Dis (2009) 2.10

Risk factors for genital HPV DNA in men resemble those found in women: a study of male attendees at a Danish STD clinic. Sex Transm Infect (2002) 2.05

Circumcision and sexual behavior: factors independently associated with human papillomavirus detection among men in the HIM study. Int J Cancer (2009) 2.01

Male sexual behavior and human papillomavirus DNA: key risk factors for cervical cancer in Spain. J Natl Cancer Inst (1996) 1.96

Correlates of homosexual behavior and the incidence of anal cancer. JAMA (1982) 1.95

Transmission of human papillomavirus in heterosexual couples. Emerg Infect Dis (2008) 1.93

Condom use and other factors affecting penile human papillomavirus detection in men attending a sexually transmitted disease clinic. Sex Transm Dis (2004) 1.87

Human papillomavirus prevalence and type distribution in male anogenital sites and semen. Cancer Epidemiol Biomarkers Prev (2007) 1.87

Prevalence and determinants of human papillomavirus genital infection in men. Br J Cancer (2002) 1.83

European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts. Sex Transm Infect (2000) 1.80

High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men. AIDS (1998) 1.79

Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys. Cancer Epidemiol Biomarkers Prev (2006) 1.77

Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents: a randomized controlled trial. Pediatr Infect Dis J (2007) 1.77

Associations between male anogenital human papillomavirus infection and circumcision by anatomic site sampled and lifetime number of female sex partners. J Infect Dis (2009) 1.74

Human papillomavirus infection in men attending a sexually transmitted disease clinic. J Infect Dis (2003) 1.74

Task force on recurrent respiratory papillomas. A preliminary report. Arch Otolaryngol Head Neck Surg (1995) 1.66

Prevalence of penile human papillomavirus DNA in husbands of women with and without cervical neoplasia: a study in Spain and Colombia. J Infect Dis (1997) 1.56

The impact of HIV antiviral therapy on human papillomavirus (HPV) infections and HPV-related diseases. Antivir Ther (2004) 1.56

Age-related prevalence of anal cancer precursors in homosexual men: the EXPLORE study. J Natl Cancer Inst (2005) 1.50

Acquisition of anal human papillomavirus (HPV) infection in women: the Hawaii HPV Cohort study. J Infect Dis (2008) 1.50

Burden of invasive squamous cell carcinoma of the penis in the United States, 1998-2003. Cancer (2008) 1.48

Role of male behavior in cervical carcinogenesis among women with one lifetime sexual partner. Cancer (1993) 1.48

Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.46

The value of including boys in an HPV vaccination programme: a cost-effectiveness analysis in a low-resource setting. Br J Cancer (2007) 1.45

Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and in genital warts. Med Microbiol Immunol (2003) 1.45

The male factor in the etiology of cervical cancer among sexually monogamous women. Int J Cancer (1989) 1.42

The psychosocial impact of human papillomavirus infection: implications for health care providers. Int J STD AIDS (1996) 1.42

Anal cancer incidence: genital warts, anal fissure or fistula, hemorrhoids, and smoking. J Natl Cancer Inst (1989) 1.42

The epidemiology of anal human papillomavirus and related neoplasia. Obstet Gynecol Clin North Am (2009) 1.34

Estimation of the impact of genital warts on health-related quality of life. Sex Transm Infect (2008) 1.31

Malignant progression of anal intra-epithelial neoplasia. ANZ J Surg (2006) 1.28

Anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual and bisexual men: prevalence and risk factors. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.18

Immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in healthy boys aged 10-18 years. J Adolesc Health (2009) 1.15

Penile lesions and human papillomavirus in male sexual partners of women with cervical intraepithelial neoplasia. J Am Acad Dermatol (2002) 1.14

Anal intraepithelial neoplasia in a multisite study of HIV-infected and high-risk HIV-uninfected women. AIDS (2009) 1.12

Risk factors for squamous cell carcinoma of the penis--population-based case-control study in Denmark. Cancer Epidemiol Biomarkers Prev (2008) 1.12

Human papillomavirus infection of the male diagnosed by Southern-blot hybridization and polymerase chain reaction: comparison between urethra samples and penile biopsy samples. J Med Virol (1991) 1.11

Human papillomavirus anogenital disease in HIV-infected individuals. Dermatol Ther (2005) 1.09

Human papillomavirus infection as a prognostic factor in oropharyngeal squamous cell carcinomas treated in a prospective phase II clinical trial. Anticancer Res (2009) 1.06

Recurrent respiratory papillomatosis. Laryngoscope (2001) 0.98

Breast and cervical cancer surveillance, United States, 1973-1987. MMWR CDC Surveill Summ (1992) 0.95

Anal cancer in renal transplant patients. Int J Colorectal Dis (2005) 0.94

History of genital warts in 10,838 women 20 to 29 years of age from the general population. Risk factors and association with Papanicolaou smear history. Sex Transm Dis (1997) 0.89

Anal carcinoma: histology, staging, epidemiology, treatment. Curr Opin Oncol (2000) 0.88

Anal and penile condylomas in HIV-negative and HIV-positive men: clinical, histological and virological characteristics correlated to therapeutic outcome. Acta Derm Venereol (1995) 0.77